Delivery Order SPE2DB22D2007-SPE2DB24FJ0AQ
Award Date 2/29/24
Potential Completion Date 3/1/24
Potential Value $1.9K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,765.48 firm fixed-price delivery order is for the supply of 20,000-unit vials of the drug Thrombin-JMI. The contract has an ultimate completion date of November 30, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award, with an ID of SPE2DB20D7061|SPE2DB25FSLH8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,490.87, is for the delivery of 5,000-unit vials of the medication Thrombin-JMI. This is a firm-fixed-price delivery order contract with a completion date of November 25, 2024. The contract does not have a set-aside designation, indicating open...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for Thrombin-JMI 5,000 unit epistaxis products valued at $1,639.81. This is a firm fixed-price delivery order with an ultimate completion date of August 29, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical...
- <p>Amerisourcebergen Drug Corp has been awarded a six hundred forty-seven dollar firm fixed price delivery order against an unspecified government-wide acquisition contract by the Defense Logistics Agency. The delivery order is for five thousand units of Thrombin-JMI five thousand units vials with an anticipated completion date of October 19, 2023. Performance will take place in Conshohocken, Pennsylvania. No set-aside designation was applied to this award.</p>
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order for 20,000 unit vials of Recothrom (thrombin topical), a hemostatic agent used in surgical applications. This firm fixed-price delivery order, valued at $7,567.75, was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical procedures. This firm fixed-price delivery order, valued at $4,839.49, represents a competitive award with no set-aside designation and is scheduled for completion by August 22, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract valued at $16,550.22 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 20,000 unit vials of the pharmaceutical product RECOTHROM. This contract has an ultimate completion date of April 15, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $16,136.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom, a topical thrombin product used in surgical hemostasis. Issued on August 22, 2025, with an ultimate completion date of August 25, 2025, this non-set-aside contract represents a child delivery order under AmerisourceBergen's larger prime indefinite delivery contract (IDC SPE2DX) valued at $999,999,999.00 through December...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical applications, with a ceiling value of $17,401.91. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 30, 2025. The award was issued on September 29, 2025, with performance occurring at AmerisourceBergen's corporate office location in...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $2,403.54 firm fixed-price contract is for the delivery of 20,000 unit vials of RECOTHROM, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 held by Amerisourcebergen with DLA Troop Support Medical, which...